ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Bayer HealthCare and India’s Zydus Cadila have formed a 50-50 pharmaceutical marketing and sales joint-venture company, Bayer Zydus Pharma, based in Mumbai. The partners will combine product portfolios and sales forces in the areas of women’s health care, diagnostic imaging, and oncology. Bayer Zydus Pharma’s portfolio will be composed of licensed drugs as well as existing Bayer and Zydus products and compounds emerging from Bayer’s pipeline. A staff of 600 will come from both companies. Meanwhile, Bayer HealthCare says it will consolidate four U.S. East Coast operations into a single facility to be built in New York or New Jersey. It will employ approximately 2,500 people.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter